| Term 
 
        | Where are endogenous opioids synthesized from? |  | Definition 
 
        | All endogenous opioids start as pro-peptides. All have a gly-gly-phe group. Cleaved at Gly-Phe and packaged into vesicles on ER. |  | 
        |  | 
        
        | Term 
 
        | Review: How does opioids receptor signalling take place? |  | Definition 
 
        | Mu receptor is a Gi receptor, blocks adenylyl cyclase --> no cAMP, no pKA --> efflux of K and hyperpolarization |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of addiction/tolerance/withdrawal? |  | Definition 
 
        | Nigrostrial and mesolimbocortical pathways mediate dopamine. VTA --> nucleus accumbens --> prefrontal cortex. Release of dopamine into NUCLEUS ACCUMBENS = reward |  | 
        |  | 
        
        | Term 
 
        | How do dynorphins and endorphins affect the nucleus accumbens and VTA? |  | Definition 
 
        | - Dynorphins - kappa ligands, slow firing of the neuron - GABA neuron synthesizes GABA --> GABAa (ionotropic) --> also slows firing of the neuron
 - Endorphins act on mu on GABA, GABA hyperpolarizes and cannot slow VTA --> more dopamine
 |  | 
        |  | 
        
        | Term 
 
        | What does chronic activation of mu do to other receptors? |  | Definition 
 
        | Tolerance - decreases cAMP, upregulation of adenylyl cyclase, downregulation of Gi and Mu Withdrawal - cAMP is higher in the ABSENCE of drug.
 |  | 
        |  | 
        
        | Term 
 
        | How does a prototype opioid (morphine) look and what is its potency? |  | Definition 
 
        | 5 fused rings, one coming up out of the structure. Amine has a single carbon - tertiary amine. (-) is analgesic
 1:6 potency IV vs. PO
 -3OH. a -3OCH3 decreases analgesia.
 |  | 
        |  | 
        
        | Term 
 
        | How is morphine metabolized? |  | Definition 
 
        | In the liver - contraindicated in liver failure - 3-conjugation - primary metabolite in oral, loss of 50% by first pass. INACTIVE --> none with IV admin.
 - 6-glucuronidation - active to a lower degree than morphine. Transferase switches between this and conjugate.
 - Normorphine - less active, through demethylation and CYP
 |  | 
        |  | 
        
        | Term 
 
        | What SAR would turn morphine into an antagonist? |  | Definition 
 
        | 3-5 carbons off the amide group Requirements for antagonism: 5 rings, oxymorphone backbone, -14OH, 3-5 C-substituted N
 - Naloxone - 3 carbons
 - Naltrexone - cyclic
 - Methylnaltrexone - quaternary amine
 - Pentazocine - kappa agonist, given w/ naloxone to prevent abuse. only 2 rings.
 - Buprenorphine - mixed analgesic, more potent than morphine, but less efficacy
 - Butorphanol - Kappa agonist, mu antagonist. More potent but less efficacy than morphine. Not orally active.
 |  | 
        |  | 
        
        | Term 
 
        | What is the SAR for codeine? How is it metabolized? |  | Definition 
 
        | Same as morphine, except -3OCH3 1:1 IV to PO, but releases histamine IV, never given IV!
 - Demethylated by 2D6 to morphine. If someone lacks 2D6 - no analgesia
 - Do not give 2d6 inhibitors - celebrex, plavix, fluconazole, SSRIs - codeine won't work.
 |  | 
        |  | 
        
        | Term 
 
        | What is diacetylmorphine? |  | Definition 
 
        | Heroine! Acetyl groups at 3- and 6-
 Very lipophilic. Hydrolyzes to be 10x more potent.
 |  | 
        |  | 
        
        | Term 
 
        | What are the SARs of hydromorphone and hydrocodone? |  | Definition 
 
        | - Reduction of 7-8 double bond decreases activity - -6-ketone increases activity = hydromorphone --> 10x morphine
 - Hydrocodone - 3-OCH3 derivative of hydromorphone. More active than codeine
 |  | 
        |  | 
        
        | Term 
 
        | What are the SARs of oxymorphone and oxycodone? |  | Definition 
 
        | As well as removing the 7-8 double bond and adding a -6-ketone, addition of -14-OH. = oxymorphone. - oxycodone --> -3-OCH3. Codeine derivative of oxymorphone, resistant to 1st pass metabolism
 |  | 
        |  | 
        
        | Term 
 
        | What are the interactions of a mu agonist in the mu binding site? |  | Definition 
 
        | - amine - anionic binding site - phenyl ring - pi stacking with lipophilic surface
 -5th ring goes into cavity
 |  | 
        |  | 
        
        | Term 
 
        | What is the SAR of meperidine and how is it used? |  | Definition 
 
        | Rapid onset and short duration - surgery Has 1 phenyl ring and 1 amine ring. 1/10 potency of morphine
 Demethylates to normeperidine which can build up to toxicity --> strong MAO interactions
 |  | 
        |  | 
        
        | Term 
 
        | What is special about the SAR of tramadol? How is tapentadol related?
 |  | Definition 
 
        | + enantiomer is a weak mu agonist - enantiomer inhibitits SERT and NET
 Is not blocked by naloxone
 - Tapentadol - structurally similar, only 1 ring instead of 2. Only blocks NET
 |  | 
        |  | 
        
        | Term 
 
        | How is methadone a useful agent? |  | Definition 
 
        | Similar in potency to morphine, (-) is active. Longer duration of potency and orally active. Used to treat symptoms of withdrawal |  | 
        |  | 
        
        | Term 
 
        | What are the SARs of the -fentanils? |  | Definition 
 
        | - Fentanyl -  80X the potency of morphine. 2 amines, short duration. pH 8.5 (base - ionized at 7.5) - Sufentanil - 4-methoxy and a thiophenyl group, 600x morphine. Used for anesthesia due to short duration.
 - Alfentanil - decreased potency and pKa. Half life 90 min.
 - Remifentanil - Super rapid metabolism
 Alf < Remi < Fentanyl < Sufen
 |  | 
        |  | 
        
        | Term 
 
        | What is the neurovascular hypothesis of migraines? |  | Definition 
 
        | Neuropeptides such as neurokinin A, Sub P, and CGRP released from trigeminal nerve --> inflammation and vasodilation. CGRP - Dilation. 5-HT - constriction |  | 
        |  | 
        
        | Term 
 
        | What is the serotonin theory of migraines? |  | Definition 
 
        | High levels = constriction low levels = dilation --> inflammation
 Plasma and platelet 5-HT conc. differ in migraines. Excretion through urinary tract
 |  | 
        |  | 
        
        | Term 
 
        | How does blocking pKA affect a blood vessel? |  | Definition 
 
        | if pKA is blocked, calcium increases due to calcium channels not being phosphorylated and PLC not inhibited Calcium increase = constriction --> 5-HT1b
 |  | 
        |  | 
        
        | Term 
 
        | Why does sumatriptan have less of a constricting effect in other vasculature? |  | Definition 
 
        | Affects only one type of serotonin receptor. Resembles the structure of serotonin. - Differences: dimethylamino and 5-methylsufonamide
 - Required: Indole ring, 2-3 carbon spacer between amide and indole. Tertiary amines more potent.
 |  | 
        |  | 
        
        | Term 
 
        | What interactions does a triptan have with the bio-amine receptor? |  | Definition 
 
        | Hydrogen bonding at I, ionic bond at the aspartate of 3 |  | 
        |  | 
        
        | Term 
 
        | What differences do triptans have? |  | Definition 
 
        | Sumatriptan - more SQ bioavailability - MAO-A inhibitor. Can incorporate sulfur into hemoglobin - Zomig - lasts longer
 - Maxalt - Fastest onset, extensive MAO, cannot give to propanolol
 - Axert - more oral bioavail. Longer acting, MAO and 2D6/3A4
 - Frova - Highest 1B affinity, long half life and not MAO metabolized
 - Amerge - not MAO metabolized
 |  | 
        |  |